Skip to main content
Clinical Trials/IRCT20230715058780N1
IRCT20230715058780N1
Recruiting
Phase 3

Comparative study of efficacy and side effects of combination Nesdonal - Fentanyl - Midazolam with Etomidate - Fentanyl - Midazolam for sedation of patients undergoing cataract surgery

Esfahan University of Medical Sciences0 sites52 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Esfahan University of Medical Sciences
Enrollment
52
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Cataract surgery candidates for emulsification method
  • Having (ASA) between 1 and 3
  • Age between 18 and 70 years
  • Consent to participate in the study

Exclusion Criteria

  • Parkinson's
  • Occurrence of acute cardiac ischemia in the last three months
  • Having a history of narcotic drugs use
  • Having a history of allergy to anesthetics
  • Weighing more than one hundred kilograms
  • Baseline blood pressure greater than 180/110

Outcomes

Primary Outcomes

Not specified

Similar Trials